Tokyo Tape
Sign in
← Oncolys BioPharma

Quarterly report · Q2

4588.TEDINET S100OV5V
Period2022-01-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥426m2022-01-01 → 2022-06-30StandaloneNet sales
Revenue¥642m2021-01-01 → 2021-12-31StandaloneNet sales (5-year summary)
Revenue¥193m2021-01-01 → 2021-06-30StandaloneNet sales
Operating income−¥659m2022-01-01 → 2022-06-30StandaloneOperating income
Operating income−¥634m2021-01-01 → 2021-06-30StandaloneOperating income
Ordinary income−¥591m2022-01-01 → 2022-06-30StandaloneOrdinary income
Ordinary income−¥1.5bn2021-01-01 → 2021-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥649m2021-01-01 → 2021-06-30StandaloneOrdinary income
Profit before tax−¥569m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Profit before tax−¥649m2021-01-01 → 2021-06-30StandaloneIncome before income taxes
Net income−¥571m2022-01-01 → 2022-06-30StandaloneProfit loss
Net income−¥1.6bn2021-01-01 → 2021-12-31StandaloneNet income loss (5-year summary)
Net income−¥651m2021-01-01 → 2021-06-30StandaloneProfit loss
Total assets¥3.5bnat 2022-06-30StandaloneAssets
Total assets¥4.3bnat 2021-12-31StandaloneAssets
Total assets¥5.2bnat 2021-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥767mat 2022-06-30StandaloneLiabilities
Total liabilities¥698mat 2021-12-31StandaloneLiabilities
Net assets / equity¥2.7bnat 2022-06-30StandaloneNet assets
Net assets / equity¥3.6bnat 2021-12-31StandaloneNet assets
Net assets / equity¥4.5bnat 2021-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥2.9bnat 2022-06-30StandaloneCash and deposits
Cash and deposits¥3.5bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥2.6bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥4.4bnat 2021-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2020-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥722m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.7bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥595m2021-01-01 → 2021-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥21m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥942,0002021-01-01 → 2021-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥327,0002021-01-01 → 2021-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥30m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥3.1bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.1bn2021-01-01 → 2021-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-32.922022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-13.942022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-95.52021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-39.452021-01-01 → 2021-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-17.352021-04-01 → 2021-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio77.9%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.6%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio86.1%at 2021-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued17,405,200at 2022-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,340,900at 2021-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 451
ItemContextValueUnit
Depreciation and amortization ope cfCurrentYTDDuration_NonConsolidatedMember155000JPY
Amortization of restricted stock remuneration ope cfPrior1YTDDuration_NonConsolidatedMember27135000JPY
Amortization of restricted stock remuneration ope cfCurrentYTDDuration_NonConsolidatedMember14289000JPY
Gain on transfer of receivables ope cfPrior1YTDDuration_NonConsolidatedMember－JPY
Gain on transfer of receivables ope cfCurrentYTDDuration_NonConsolidatedMember-21406000JPY
Share based compensation expenses ope cfPrior1YTDDuration_NonConsolidatedMember156659000JPY
Share based compensation expenses ope cfCurrentYTDDuration_NonConsolidatedMember41705000JPY
Increase decrease in provision for retirement benefits ope cfPrior1YTDDuration_NonConsolidatedMember367000JPY
Increase decrease in provision for retirement benefits ope cfCurrentYTDDuration_NonConsolidatedMember1792000JPY
Interest and dividends income ope cfPrior1YTDDuration_NonConsolidatedMember-241000JPY
Interest and dividends income ope cfCurrentYTDDuration_NonConsolidatedMember-287000JPY
Interest expenses ope cfPrior1YTDDuration_NonConsolidatedMember2109000JPY
Interest expenses ope cfCurrentYTDDuration_NonConsolidatedMember1937000JPY
Foreign exchange losses gains ope cfPrior1YTDDuration_NonConsolidatedMember-27452000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration_NonConsolidatedMember-82550000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration_NonConsolidatedMember-40168000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration_NonConsolidatedMember321697000JPY
Decrease increase in inventories ope cfPrior1YTDDuration_NonConsolidatedMember-507000JPY
Decrease increase in inventories ope cfCurrentYTDDuration_NonConsolidatedMember251000JPY
Decrease increase in prepaid expenses ope cfPrior1YTDDuration_NonConsolidatedMember-40530000JPY
Decrease increase in prepaid expenses ope cfCurrentYTDDuration_NonConsolidatedMember-6679000JPY
Decrease increase in accounts receivable other ope cfPrior1YTDDuration_NonConsolidatedMember1398000JPY
Decrease increase in accounts receivable other ope cfCurrentYTDDuration_NonConsolidatedMember-77824000JPY
Decrease increase in consumption taxes refund receivable ope cfPrior1YTDDuration_NonConsolidatedMember83295000JPY
Decrease increase in consumption taxes refund receivable ope cfCurrentYTDDuration_NonConsolidatedMember-21868000JPY
Decrease increase in advance payment ope cfPrior1YTDDuration_NonConsolidatedMember-16032000JPY
Decrease increase in advance payment ope cfCurrentYTDDuration_NonConsolidatedMember-68762000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration_NonConsolidatedMember-122086000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration_NonConsolidatedMember-49980000JPY
Increase decrease in contract liabilities ope cfPrior1YTDDuration_NonConsolidatedMember－JPY
Increase decrease in contract liabilities ope cfCurrentYTDDuration_NonConsolidatedMember-151697000JPY
Other net ope cfPrior1YTDDuration_NonConsolidatedMember33395000JPY
Other net ope cfCurrentYTDDuration_NonConsolidatedMember-51383000JPY
Subtotal ope cfPrior1YTDDuration_NonConsolidatedMember-588619000JPY
Subtotal ope cfCurrentYTDDuration_NonConsolidatedMember-719719000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration_NonConsolidatedMember136000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration_NonConsolidatedMember154000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration_NonConsolidatedMember-2387000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration_NonConsolidatedMember-2189000JPY
Income taxes paid ope cfPrior1YTDDuration_NonConsolidatedMember-3719000JPY
Income taxes paid ope cfCurrentYTDDuration_NonConsolidatedMember-728000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration_NonConsolidatedMember-594589000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration_NonConsolidatedMember-722482000JPY
Proceeds from sales of investment securities inv cfPrior1YTDDuration_NonConsolidatedMember486000JPY
Proceeds from sales of investment securities inv cfCurrentYTDDuration_NonConsolidatedMember－JPY
Proceeds from selling credit inv cfPrior1YTDDuration_NonConsolidatedMember－JPY
Proceeds from selling credit inv cfCurrentYTDDuration_NonConsolidatedMember21406000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration_NonConsolidatedMember-743000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration_NonConsolidatedMember-635000JPY
Payments for lease and guarantee deposits inv cfPrior1YTDDuration_NonConsolidatedMember-71000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-06-30pass